Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-L1 and tumor-associated macrophages in de novo DLBCL
Ronald McCord, Christopher R. Bolen, Hartmut Koeppen, et al.
Blood Advances (2019) Vol. 3, Iss. 4, pp. 531-540
Open Access | Times Cited: 68

Showing 1-25 of 68 citing articles:

The immune landscape and response to immune checkpoint blockade therapy in lymphoma
Justin Kline, James Godfrey, Stephen M. Ansell
Blood (2019) Vol. 135, Iss. 8, pp. 523-533
Open Access | Times Cited: 152
Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy
Wei Li, Fenglei Wu, Shaolin Zhao, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 67, pp. 49-57
Open Access | Times Cited: 95
Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis
Chun Gong, Joanna A. Krupka, Jie Gao, et al.
Molecular Cell (2021) Vol. 81, Iss. 19, pp. 4059-4075.e11
Open Access | Times Cited: 62
Prostate cancer immunotherapy: a review of recent advancements with novel treatment methods and efficacy.
Ian Wang, Liankun Song, Beverly Y. Wang, et al.
PubMed (2022) Vol. 10, Iss. 4, pp. 210-233
Closed Access | Times Cited: 50
The Immunology of DLBCL
Taishi Takahara, Shigeo Nakamura, Toyonori Tsuzuki, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 835-835
Open Access | Times Cited: 33
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation
Matthew J. Frigault, Philippe Armand, Robert Redd, et al.
Blood Advances (2020) Vol. 4, Iss. 1, pp. 122-126
Open Access | Times Cited: 56
Genetic modification of primary human B cells to model high-grade lymphoma
Rebecca Caeser, Miriam Di Re, Joanna A. Krupka, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 56
Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?
Clara Martori, Lidia Sánchez-Moral, Tony Paul, et al.
Cancers (2022) Vol. 14, Iss. 2, pp. 440-440
Open Access | Times Cited: 33
Clinical Impact of Immune Cells and Their Spatial Interactions in Diffuse Large B-Cell Lymphoma Microenvironment
Matias Autio, Suvi‐Katri Leivonen, Oscar Brück, et al.
Clinical Cancer Research (2021) Vol. 28, Iss. 4, pp. 781-792
Open Access | Times Cited: 33
Accurate expression of PD‐L1/L2 in lung adenocarcinoma cells: A retrospective study by double immunohistochemistry
Yusuke Shinchi, Yoshihiro Komohara, Kimihiro Yonemitsu, et al.
Cancer Science (2019) Vol. 110, Iss. 9, pp. 2711-2721
Open Access | Times Cited: 38
The immune contexture of primary central nervous system diffuse large B cell lymphoma associates with patient survival and specific cell signaling
Mélissa Alame, Emmanuel Cornillot, Valère Cacheux, et al.
Theranostics (2021) Vol. 11, Iss. 8, pp. 3565-3579
Open Access | Times Cited: 28
Targeting of PIM Kinases Shows Single Agent Efficacy and Synergizes With BCL2 Inhibitors in Diffuse Large B Cell Lymphoma of the ABC Subtype
C. Tarantelli, Omar Kayali, Elisa Civanelli, et al.
Hematological Oncology (2025) Vol. 43, Iss. 2
Closed Access
Proteome alterations in peripheral immune cells of DLBCL patients and evidence of cancer extracellular vesicles involvement
Mostafa Ejtehadifar, Sara Zahedi, Paula Gameiro, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2025), pp. 167842-167842
Open Access
PDL1-expressing macrophages infiltrate diffuse large B-cell lymphoma and promote lymphoma growth in a MYC-driven experimental model
Ningxuan Cui, Peter Leary, Vanesa‐Sindi Ivanova, et al.
Blood Cancer Journal (2025) Vol. 15, Iss. 1
Open Access
Prognostic impact of PD-L1 expression in primary gastric and intestinal diffuse large B-cell lymphoma
Eri Ishikawa, Masanao Nakamura, Kazuyuki Shimada, et al.
Journal of Gastroenterology (2019) Vol. 55, Iss. 1, pp. 39-50
Closed Access | Times Cited: 31
The Tumor Microenvironment of DLBCL in the Computational Era
Giuseppina Opinto, Maria Carmela Vegliante, Antonio Negri, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 29
Tumor-associated macrophages in lymphoma: From mechanisms to therapy
Xingfang Xiong, Xiaoli Xie, Zhiqiang Wang, et al.
International Immunopharmacology (2022) Vol. 112, pp. 109235-109235
Closed Access | Times Cited: 18
Challenges and the Evolving Landscape of Assessing Blood-Based PD-L1 Expression as a Biomarker for Anti-PD-(L)1 Immunotherapy
Tao Wang, Desirée Denman, Silvia M. Bacot, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1181-1181
Open Access | Times Cited: 16
Potential Pathogenic Impact of Cow’s Milk Consumption and Bovine Milk-Derived Exosomal MicroRNAs in Diffuse Large B-Cell Lymphoma
Bodo C. Melnik, Rudolf Stadler, Ralf Weiskirchen, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6102-6102
Open Access | Times Cited: 10
Anti-lung cancer synergy of low-dose doxorubicin and PD-L1 blocker co-delivered via mild photothermia-responsive black phosphorus
Hua‐Zhen Xu, Fei-Xiang Chen, Ke Li, et al.
Drug Delivery and Translational Research (2024)
Closed Access | Times Cited: 3
PD‐L1+ macrophage and tumor cell abundance and proximity to T cells in the pretreatment large B‐cell lymphoma microenvironment impact CD19 CAR‐T cell immunotherapy efficacy
Alexandre V. Hirayama, Jocelyn H. Wright, Kimberly S. Smythe, et al.
HemaSphere (2024) Vol. 8, Iss. 8
Open Access | Times Cited: 3
EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 1)
Magda Zanelli, Francesca Sanguedolce, Andrea Palicelli, et al.
Cancers (2021) Vol. 13, Iss. 18, pp. 4578-4578
Open Access | Times Cited: 22
Epigenetic, Metabolic, and Immune Crosstalk in Germinal-Center-Derived B-Cell Lymphomas: Unveiling New Vulnerabilities for Rational Combination Therapies
Inna Serganova, Sanjukta Chakraborty, Samuel Yamshon, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 9
Open Access | Times Cited: 14
Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies
Yutong Xie, Huan Yang, Chao Yang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 13
Mesenchymal stem cells-macrophages crosstalk and myeloid malignancy
Kun Li, Hongyan Nie, Runming Jin, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top